Surgery versus radiation for clinically positive nodal prostate cancer in an other cause mortality risk weighted cohort
International Urology and Nephrology · 2024
DOI: 10.1007/s11255-024-04253-9 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Urology and Nephrology, 2024. Verfasst von Shane A Tinsley und 18 weiteren Autor:innen. Beteiligte Einrichtung: Analysis, and Evaluation, Henry Ford Health, VUI Center for Outcomes Research, 2799 W Grand Blvd, Detroit, MI, 48202, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Menon Foundation, Vattikuti Foundation.
Abstract (Originalsprache)
PURPOSE: This study examined cancer control metrics between surgery and radiation for clinically positive nodal prostate cancer in an other-cause mortality weighted cohort, to circumvent limitations in previous studies. METHODS: The Surveillance, Epidemiology, and End Results Research Plus database was queried to identify men with clinically positive nodal prostate cancer at diagnosis between 2004 and 2017 who were treated with surgery or radiation. A competing-risks regression model was used to calculate the 10-year other-cause mortality risk using available covariates, including treatment type. Inverse probability of treatment weighting was then used to balance covariates, including other-cause mortality risk. Then, competing-risks cumulative incidence curves and multivariable models, which were weighted on the calculated other-cause mortality risk, were used to examine the impact of treatment type on cancer-specific mortality, after accounting for covariates. RESULTS: 4739 patients underwent surgery whereas 1039 underwent radiation. The median follow-up was 4.7 years (2.6-8.2). Other-cause mortality was statistically different between treatment arms in the unweighted cohort (Gray's p = 0.005), but that difference disappeared in the weighted cohort (Gray's p = 0.2). At 10 years, the cancer-specific mortality rate was 27.6% (22.2-33.9) for radiation versus 18.1% (16.2-20.3) for surgery (p < 0.001). On competing-risks multivariable analysis, radiation had 1.86-fold (95% CI 1.69-2.12) higher hazard likelihood from one year to the next compared to surgery (p < 0.001). CONCLUSION: Clinically positive nodal patients treated with radiation fare worst cancer-specific mortality than those that underwent surgery, using calculated other-cause mortality risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Analysis, and Evaluation, Henry Ford Health, VUI Center for Outcomes Research, 2799 W Grand Blvd, Detroit, MI, 48202, USA.
- Public Health Sciences, Henry Ford Health, Detroit, MI, USA.
- Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
- Wayne State University School of Medicine, Detroit, MI, USA.
Förderung
- Menon Foundation
- Vattikuti Foundation
Zitieren
APA
Tinsley, S. A., Stephens, A., Finati, M., Chiarelli, G., Cirulli, G. O., Morrison, C., Richard, C., Hares, K., Lutchka, J., Sood, A., Buffi, N., Lughezzani, G., Bettocchi, C., Salonia, A., Briganti, A., Montorsi, F., Carrieri, G., Rogers, C., & Abdollah, F. (2024). Surgery versus radiation for clinically positive nodal prostate cancer in an other cause mortality risk weighted cohort. International Urology and Nephrology. https://doi.org/10.1007/s11255-024-04253-9
Vancouver
Tinsley SA, Stephens A, Finati M, Chiarelli G, Cirulli GO, Morrison C, et al. Surgery versus radiation for clinically positive nodal prostate cancer in an other cause mortality risk weighted cohort. International Urology and Nephrology. 2024. doi:10.1007/s11255-024-04253-9
BibTeX
@article{Tinsley2024,
author = {Tinsley, Shane A and Stephens, Alex and Finati, Marco and Chiarelli, Giuseppe and Cirulli, Giuseppe Ottone and Morrison, Chase and Richard, Caleb and Hares, Keinnan and Lutchka, Jonathan and Sood, Akshay and Buffi, Nicolò and Lughezzani, Giovanni and Bettocchi, Carlo and Salonia, Andrea and Briganti, Alberto and Montorsi, Francesco and Carrieri, Giuseppe and Rogers, Craig and Abdollah, Firas},
title = {Surgery versus radiation for clinically positive nodal prostate cancer in an other cause mortality risk weighted cohort},
journal = {International Urology and Nephrology},
year = {2024},
doi = {10.1007/s11255-024-04253-9}
}
EUVIMED